CoChat

Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning

Dong, Ruihan, Liu, Rongrong, Liu, Ziyu, Liu, Yangang, Zhao, Gaomei, Li, Honglei, Hou, Shiyuan, Ma, Xiaohan, Kang, Huarui, Liu, Jing, Guo, Fei, Zhao, Ping, Wang, Junping, Wang, Cheng, Wu, Xingan, Ye, Sheng, Zhu, Cheng · 2025 · eLife

Published version of a preprint

Cited by 25

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant Acinetobacter baumannii , while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.97330.3

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 51

  1. Allsopp, 2022, Antimicrobial peptide mechanism studied by scattering-guided molecular dynamics simulation, The Journal of Physical Chemistry. B, 126, 6922, 10.1021/acs.jpcb.2c03193 · doi:10.1021/acs.jpcb.2c03193
  2. Atchley, 2005, Solving the protein sequence metric problem, PNAS, 102, 6395, 10.1073/pnas.0408677102 · DOI · Paper page
  3. Best, 2012, Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles, Journal of Chemical Theory and Computation, 8, 3257, 10.1021/ct300400x · DOI · Paper page
  4. Chung, 2016, Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii, Scientific Reports, 6, 10.1038/srep28168 · DOI
  5. Das, 2021, Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations, Nature Biomedical Engineering, 5, 613, 10.1038/s41551-021-00689-x · DOI · Paper page
  6. Dean, 2021, PepVAE: variational autoencoder framework for antimicrobial peptide generation and activity prediction, Frontiers in Microbiology, 12, 10.3389/fmicb.2021.725727 · DOI · Paper page
  7. De Oliveira, 2020, Antimicrobial resistance in ESKAPE pathogens, Clinical Microbiology Reviews, 33, 10.1128/CMR.00181-19 · DOI · Paper page
  8. Dong R. 2024a. GAN-for-AMP-design. Software Heritage. swh:1:rev:801e7c05df272db0da1bbbf3f34f1a25da9c7336. https://archive.softwareheritage.org/swh:1:dir:ca7da2ca565efa01943a4873650e3b8876da7b4b;origin=https://github.com/ruihan-dong/GAN-for-AMP-Design;visit=swh:1:snp:c2f2cabd4d0dc78d3aa7352e8456c241f2339eab;anchor=swh:1:rev:801e7c05df272db0da1bbbf3f34f1a25da9c7336.
  9. Dong R. 2024b. AMPredictor. Software Heritage. swh:1:rev:49daae2e5d436ddfe42fe3f5650b09890034f8c6. https://archive.softwareheritage.org/swh:1:dir:d854a87598629689ab2724be8352ae6dee2eadbb;origin=https://github.com/ruihan-dong/AMPredictor;visit=swh:1:snp:ca158598f4dbe3831256f3da191b6bc49d847755;anchor=swh:1:rev:49daae2e5d436ddfe42fe3f5650b09890034f8c6.
  10. Gao, 2020, Complete genome sequence of Pseudomonas aeruginosa XN-1, isolated from the sputum of a severe pneumonia patient, microbiology resource announcements, 9, 10.1128/MRA.00653-20 · doi:10.1128/mra.00653-20
  11. Goodfellow IJ, Pouget-Abadie J, Mirza M, Xu B, Warde-Farley D, Ozair S, Courville A, Bengio Y. 2014. Generative Adversarial Nets. Advances in Neural Information Processing Systems.
  12. Huan, 2020, Antimicrobial peptides: classification, design, application and research progress in multiple fields, Frontiers in Microbiology, 11, 10.3389/fmicb.2020.582779 · DOI · Paper page
  13. Huang, 2021, DeepPurpose: a deep learning library for drug–target interaction prediction, Bioinformatics, 36, 5545, 10.1093/bioinformatics/btaa1005 · DOI · Paper page
  14. Huang, 2023, Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences, Nature Biomedical Engineering, 7, 797, 10.1038/s41551-022-00991-2 · DOI · Paper page
  15. Hutchings, 2019, Antibiotics: past, present and future, Current Opinion in Microbiology, 51, 72, 10.1016/j.mib.2019.10.008 · DOI · Paper page
  16. Kitchen, 2004, Docking and scoring in virtual screening for drug discovery: methods and applications, Nature Reviews. Drug Discovery, 3, 935, 10.1038/nrd1549 · DOI · Paper page
  17. Klauda, 2010, Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types, The Journal of Physical Chemistry. B, 114, 7830, 10.1021/jp101759q · DOI · Paper page
  18. Lee, 2016, Molecular insights into the adsorption mechanism of human β-defensin-3 on bacterial membranes, Langmuir, 32, 1782, 10.1021/acs.langmuir.5b04113 · DOI
  19. Lewies, 2019, Antimicrobial peptides: the achilles’ heel of antibiotic resistance?, Probiotics and Antimicrobial Proteins, 11, 370, 10.1007/s12602-018-9465-0 · DOI · Paper page
  20. Li, 2020, DeepAVP: a dual-channel deep neural network for identifying variable-length antiviral peptides, IEEE Journal of Biomedical and Health Informatics, 24, 3012, 10.1109/JBHI.2020.2977091 · DOI
  21. Li, 2022, AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens, BMC Genomics, 23, 10.1186/s12864-022-08310-4 · DOI · Paper page
  22. Lin, 2022, AI4AVP: an antiviral peptides predictor in deep learning approach with generative adversarial network data augmentation, Bioinformatics Advances, 2, 10.1093/bioadv/vbac080 · DOI
  23. Liu, 2022, Bomidin: an optimized antimicrobial peptide with broad antiviral activity against enveloped viruses, Frontiers in Immunology, 13, 10.3389/fimmu.2022.851642 · doi:10.3389/fimmu.2022.851642
  24. Ma, 2022, Identification of antimicrobial peptides from the human gut microbiome using deep learning, Nature Biotechnology, 40, 921, 10.1038/s41587-022-01226-0 · DOI · Paper page
  25. Maasch, 2023, Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning, Cell Host & Microbe, 31, 1260, 10.1016/j.chom.2023.07.001 · DOI · Paper page
  26. Mahlapuu, 2016, Antimicrobial peptides: an emerging category of therapeutic agents, Frontiers in Cellular and Infection Microbiology, 6, 10.3389/fcimb.2016.00194 · DOI · Paper page
  27. Murray, 2022, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, The Lancet, 399, 629, 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
  28. Oddo, 2017, Hemolytic activity of antimicrobial peptides, Methods in Molecular Biology, 1548, 427, 10.1007/978-1-4939-6737-7_31 · doi:10.1007/978-1-4939-6737-7_31
  29. Pang, 2022, Integrating transformer and imbalanced multi-label learning to identify antimicrobial peptides and their functional activities, Bioinformatics, 38, 5368, 10.1093/bioinformatics/btac711 · DOI
  30. Pirtskhalava, 2021, DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics, Nucleic Acids Research, 49, D288, 10.1093/nar/gkaa991 · DOI · Paper page
  31. Qureshi, 2015, AVP-IC50 Pred: multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50), Biopolymers, 104, 753, 10.1002/bip.22703 · DOI
  32. Schissel, 2021, Deep learning to design nuclear-targeting abiotic miniproteins, Nature Chemistry, 13, 992, 10.1038/s41557-021-00766-3 · DOI · Paper page
  33. Sharma, 2022, Deep-AVPpred: artificial intelligence driven discovery of peptide drugs for viral infections, IEEE Journal of Biomedical and Health Informatics, 26, 5067, 10.1109/JBHI.2021.3130825 · DOI
  34. Shi, 2022, DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides, Nucleic Acids Research, 50, D488, 10.1093/nar/gkab651 · DOI · Paper page
  35. Spohn, 2019, Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance, Nature Communications, 10, 10.1038/s41467-019-12364-6 · DOI · Paper page
  36. Timmons, 2020, HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks, Scientific Reports, 10, 10.1038/s41598-020-67701-3 · DOI
  37. Timmons, 2021, ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides, Briefings in Bioinformatics, 22, 10.1093/bib/bbab258 · DOI
  38. Torres, 2022, Mining for encrypted peptide antibiotics in the human proteome, Nature Biomedical Engineering, 6, 67, 10.1038/s41551-021-00801-1 · DOI · Paper page
  39. Tucs, 2020, Generating ampicillin-level antimicrobial peptides with activity-aware generative adversarial networks, ACS Omega, 5, 22847, 10.1021/acsomega.0c02088 · DOI
  40. Tzu-Tang, 2021, Discovering Novel Antimicrobial Peptides in Generative Adversarial Network, 10.1101/2021.11.22.469634 · DOI · Paper page
  41. Van Oort, 2021, AMPGAN v2: machine learning-guided design of antimicrobial peptides, Journal of Chemical Information and Modeling, 61, 2198, 10.1021/acs.jcim.0c01441 · DOI · Paper page
  42. Wang, 2016, APD3: the antimicrobial peptide database as a tool for research and education, Nucleic Acids Research, 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  43. Wang, 2018, A simplified derivative of human defensin 5 with potent and efficient activity against multidrug-resistant acinetobacter baumannii, Antimicrobial Agents and Chemotherapy, 62, 10.1128/AAC.01504-17 · doi:10.1128/aac.01504-17
  44. Witten, 2019, Deep learning regression model for antimicrobial peptide design, Bioinformatics, 01, 10.1101/692681 · DOI · Paper page
  45. Wu, 1999, Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane, The Journal of Biological Chemistry, 274, 29, 10.1074/jbc.274.1.29 · DOI · Paper page
  46. Wu, 2014, CHARMM-GUI Membrane Builder toward realistic biological membrane simulations, Journal of Computational Chemistry, 35, 1997, 10.1002/jcc.23702 · DOI · Paper page
  47. Xu, 2021, Comprehensive assessment of machine learning-based methods for predicting antimicrobial peptides, Briefings in Bioinformatics, 22, 10.1093/bib/bbab083 · DOI · Paper page
  48. Yan, 2020, Deep-AmPEP30: improve short antimicrobial peptides prediction with deep learning, Molecular Therapy - Nucleic Acids, 20, 882, 10.1016/j.omtn.2020.05.006 · DOI · Paper page
  49. Yan, 2023, sAMPpred-GAT: prediction of antimicrobial peptide by graph attention network and predicted peptide structure, Bioinformatics, 39, 10.1093/bioinformatics/btac715 · DOI · Paper page
  50. Zhao, 2019, Succinylated casein-coated peptide-mesoporous silica nanoparticles as an antibiotic against intestinal bacterial infection, Biomaterials Science, 7, 2440, 10.1039/c9bm00003h · doi:10.1039/c9bm00003h
  51. Zhao, 2022, γ-core guided antibiotic design based on human enteric defensin 5, Membranes, 13, 10.3390/membranes13010051 · DOI

Cited by

See all 25

Metadata

Authors
Dong, R., Liu, R., Liu, Z., Liu, Y., Zhao, G., Li, H., Hou, S., Ma, X., Kang, H., Liu, J., Guo, F., Zhao, P., Wang, J., Wang, C., Wu, X., Ye, S., & Zhu, C.
Venue
eLife
Published
2025-03-13
Volume
13
ISSN
2050-084X
Cited by
25
References
8
Language
en
Funders
  • National Key Research and Development Program of China (2020YFA0908500)
  • National Natural Science Foundation of China (22007071, 31971127, 82272330, 32100122, 62322215)
  • Natural Science Basic Research Program Key Projects of Shaanxi Province (2024JC-ZDXM-42)
  • Shanghai Sailing Program (21YF1457800)
  • Independent Research Project of State of Key Laboratory of Trauma and Chemical Poisoning (SKLYQ202101)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning. https://app.cochat.ai/papers/10.7554/elife.97330.3
The paper
Dong, R., Liu, R., Liu, Z., Liu, Y., Zhao, G., Li, H., Hou, S., Ma, X., Kang, H., Liu, J., Guo, F., Zhao, P., Wang, J., Wang, C., Wu, X., Ye, S., & Zhu, C. (2025). Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning. eLife. https://doi.org/10.7554/elife.97330.3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.